This link has been bookmarked by 1 people . It was first bookmarked on 29 Sep 2009, by Sigalon - The Swedish Frog.
-
Sigalon - The Swedish FrogTeva Pharmaceutical Industries last week revealed positive results for the drug it developed in-house to treat Parkinson's disease.
Teva, the world's biggest maker of generic drugs, stated that a daily 1-milligram dose of Azilect slowed the progression of Parkinson's disease in a Phase III clinical trial. Parkinson's has until now been characterized by inevitable progression of nervous system degeneration.
Advertisement
The Israeli company is promoting the drug together with the Danish company Lundbeck in Britain, Germany and France.
Would you like to comment?
Join Diigo for a free account, or sign in if you are already a member.